Acadian Asset Management LLC Boosts Position in Humana Inc. (HUM)

Acadian Asset Management LLC increased its stake in shares of Humana Inc. (NYSE:HUM) by 1,340.0% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 420,578 shares of the insurance provider’s stock after buying an additional 391,372 shares during the period. Acadian Asset Management LLC’s holdings in Humana were worth $101,199,000 as of its most recent filing with the SEC.

Other large investors also recently bought and sold shares of the company. Independent Portfolio Consultants Inc. boosted its stake in Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock valued at $125,000 after buying an additional 94 shares in the last quarter. Guardian Life Insurance Co. of America boosted its stake in Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after buying an additional 4 shares in the last quarter. Point72 Asia Hong Kong Ltd bought a new stake in Humana during the first quarter valued at approximately $128,000. Westbourne Investment Advisors Inc. bought a new stake in Humana during the second quarter valued at approximately $205,000. Finally, Hengehold Capital Management LLC bought a new stake in Humana during the second quarter valued at approximately $209,000. 99.08% of the stock is currently owned by institutional investors and hedge funds.

Humana Inc. (HUM) opened at 233.50 on Thursday. The firm has a market cap of $33.70 billion, a price-to-earnings ratio of 23.80 and a beta of 0.91. The firm’s 50 day moving average is $236.02 and its 200-day moving average is $219.72. Humana Inc. has a 12 month low of $163.50 and a 12 month high of $243.74.

Humana (NYSE:HUM) last released its earnings results on Wednesday, May 3rd. The insurance provider reported $2.75 EPS for the quarter, topping analysts’ consensus estimates of $2.55 by $0.20. Humana had a net margin of 2.71% and a return on equity of 14.38%. The company had revenue of $13.76 billion for the quarter, compared to analysts’ expectations of $13.61 billion. During the same quarter last year, the business earned $1.86 EPS. On average, equities analysts forecast that Humana Inc. will post $11.15 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Week Herald and is owned by of Week Herald. If you are viewing this piece of content on another site, it was stolen and republished in violation of U.S. and international copyright legislation. The legal version of this piece of content can be viewed at https://weekherald.com/2017/07/27/acadian-asset-management-llc-boosts-position-in-humana-inc-hum.html.

Several research firms recently commented on HUM. UBS AG reaffirmed a “neutral” rating and issued a $237.00 price objective (up from $205.00) on shares of Humana in a research report on Wednesday, June 28th. Zacks Investment Research cut shares of Humana from a “hold” rating to a “sell” rating in a research report on Thursday. Cowen and Company reaffirmed a “buy” rating and issued a $230.00 price objective on shares of Humana in a research report on Friday, July 14th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $246.00 price objective on shares of Humana in a research report on Friday, July 14th. Finally, BidaskClub cut shares of Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, July 19th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $236.00.

In other Humana news, VP Heidi S. Margulis sold 1,500 shares of the stock in a transaction that occurred on Friday, May 26th. The shares were sold at an average price of $231.96, for a total transaction of $347,940.00. Following the completion of the sale, the vice president now directly owns 8,150 shares of the company’s stock, valued at approximately $1,890,474. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Brian P. Leclaire sold 4,971 shares of the stock in a transaction that occurred on Wednesday, June 28th. The shares were sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the sale, the senior vice president now directly owns 14,258 shares of the company’s stock, valued at $3,421,920. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 143,241 shares of company stock valued at $32,446,903. Insiders own 0.80% of the company’s stock.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)




Receive News & Ratings for Humana Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Humana Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a Reply